Marshall Wace, LLP Aquestive Therapeutics, Inc. Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.31 - $4.5 $177,906 - $346,572
77,016 New
77,016 $200,000
Q4 2023

Feb 14, 2024
SELL
$1.29 - $2.47 $28,283 - $54,154
-21,925 Reduced 7.05%
288,884 $583,000
Q3 2023

Nov 14, 2023
BUY
$1.5 - $2.24 $57,621 - $86,047
38,414 Added 14.1%
310,809 $475,000
Q2 2023

Aug 14, 2023
BUY
$1.06 - $2.49 $288,738 - $678,263
272,395 New
272,395 $449,000

Others Institutions Holding AQST

# of Institutions
122
Shares Held
46.8M
Call Options Held
517K
Put Options Held
207K
View Full List

About Aquestive Therapeutics, Inc.

AQST Quotes by TradingView
  • Ticker AQST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,350,700
  • Market Cap $265M
  • Description
  • Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...
More about AQST
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email